Polymorphisms in the caspase-8 gene and the risk of lung cancer.

Caspase-8 (CASP-8) is an initiator CASP in the cell death receptor-mediated apoptotic pathway, and plays an important role in the development of cancer. Polymorphisms and their haplotypes in the CASP-8 gene can result in alterations in CASP-8 expression and/or activity, thereby modulating the susceptibility to lung cancer. To test this hypothesis, we examined the association of -678_-673delAGTAAG (-678del) and IVS12-19G-->A polymorphisms and their haplotypes with the risk of lung cancer in a Korean population. The CASP-8 genotypes were determined in 432 lung cancer patients and 432 healthy age- and gender-matched control subjects. The distributions of the CASP-8 -678del and IVS12-19G-->A genotypes were not significantly different between the overall lung cancer cases and the controls. When the cases were categorized by tumor histology, however, the IVS12-19 AA genotype and the combined IVS12-19 GA + AA genotype were associated with a significantly decreased risk of small cell carcinoma (SmCC) compared with the IVS12-19 GG genotype [adjusted odds ratio (OR) = 0.14, 95% confidence interval (CI) = 0.03-0.64, P = 0.01; and adjusted OR = 0.56, 95% CI = 0.33-0.96, P = 0.03, respectively]. Consistent with the genotyping analyses, the -678del-/IVS12-19A haplotype containing 94% of the IVS12-19A allele in the study population was associated with a significantly decreased risk of SmCC compared with the -678del-/IVS12-19G (adjusted OR = 0.58, 95% CI = 0.36-0.93, P = 0.023, and Pc = 0.046). These findings suggest that the CASP-8 gene may contribute to an inherited predisposition to SmCC of the lung.

[1]  B. Ponder,et al.  Association of a common variant of the CASP8 gene with reduced risk of breast cancer. , 2004, Journal of the National Cancer Institute.

[2]  Christine B Ambrosone,et al.  SNPs, haplotypes, and cancer: applications in molecular epidemiology. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[3]  V. Dixit,et al.  Apoptosis control by death and decoy receptors. , 1999, Current opinion in cell biology.

[4]  J. Blenis,et al.  Death Receptor Recruitment of Endogenous Caspase-10 and Apoptosis Initiation in the Absence of Caspase-8* , 2001, The Journal of Biological Chemistry.

[5]  M. Peter,et al.  FLICE Is Predominantly Expressed as Two Functionally Active Isoforms, Caspase-8/a and Caspase-8/b* , 1997, The Journal of Biological Chemistry.

[6]  D. Christiani,et al.  Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma. , 2001, Cancer research.

[7]  A. Gazdar,et al.  Apoptosis and lung cancer: A review , 2003, Journal of cellular biochemistry.

[8]  N. Risch.  Searching for genetic determinants in the new millennium , 2000, Nature.

[9]  N. Thornberry,et al.  Caspases: killer proteases. , 1997, Trends in biochemical sciences.

[10]  M. Lutter,et al.  Biochemical pathways of caspase activation during apoptosis. , 1999, Annual review of cell and developmental biology.

[11]  J. Tschopp,et al.  TRAIL receptor-2 signals apoptosis through FADD and caspase-8 , 2000, Nature Cell Biology.

[12]  C. Harris,et al.  Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  M. Nguyen,et al.  The procaspase-8 isoform, procaspase-8L, recruited to the BAP31 complex at the endoplasmic reticulum , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Amin,et al.  Cigarette smoking and adenocarcinoma of the lung: The relevance of nicotine-derived N-nitrosamines , 1993 .

[15]  Alexei Degterev,et al.  A decade of caspases , 2003, Oncogene.

[16]  Kenshi Hayashi,et al.  Characterization of caspase-8L: a novel isoform of caspase-8 that behaves as an inhibitor of the caspase cascade. , 2002, Blood.

[17]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[18]  John D Minna,et al.  Differential Inactivation of Caspase-8 in Lung Cancers , 2002, Cancer biology & therapy.

[19]  W. Tan,et al.  Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer , 2005, Journal of Medical Genetics.

[20]  J. Park,et al.  Methyl-CpG Binding Domain 1 Gene Polymorphisms and Risk of Primary Lung Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[21]  W. Tan,et al.  Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. , 2004, Journal of the National Cancer Institute.

[22]  J. Park,et al.  Vascular Endothelial Growth Factor Gene Polymorphisms and Risk of Primary Lung Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[23]  J. Park,et al.  DNMT3B polymorphisms and risk of primary lung cancer. , 2004, Carcinogenesis.

[24]  G. Grimmer,et al.  Experimental studies in rat lungs on the carcinogenicity and dose-response relationships of eight frequently occurring environmental polycyclic aromatic hydrocarbons. , 1983, Journal of the National Cancer Institute.

[25]  L. Eckhart,et al.  Alternative splicing of caspase-8 mRNA during differentiation of human leukocytes. , 2001, Biochemical and biophysical research communications.

[26]  M. Spitz,et al.  Ethnic differences in poly(ADP-ribose) polymerase pseudogene genotype distribution and association with lung cancer risk. , 1999, Carcinogenesis.

[27]  B. Joseph,et al.  Differences in expression of pro-caspases in small cell and non-small cell lung carcinoma. , 1999, Biochemical and biophysical research communications.

[28]  Martin Raff,et al.  Cell suicide for beginners , 1998, Nature.

[29]  J. Minna,et al.  Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification , 2002, Oncogene.

[30]  J. Liu,et al.  Apoptosome dysfunction in human cancer , 2004, Apoptosis.

[31]  H. Jeon,et al.  XPC polymorphisms and lung cancer risk , 2005, International journal of cancer.

[32]  Y. Soini,et al.  Histopathological evaluation of apoptosis in cancer. , 1998, The American journal of pathology.

[33]  C. Thompson,et al.  Apoptosis in the pathogenesis and treatment of disease , 1995, Science.

[34]  R. Lewontin,et al.  On measures of gametic disequilibrium. , 1988, Genetics.

[35]  M. Spitz,et al.  Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer. , 2003, Lung cancer.

[36]  J. Blenis,et al.  Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade , 1998, Current Biology.